LASS1 Antibodies

Santa Cruz Biotechnology provides a broad selection of LASS1 monoclonal antibodies for research in lipid metabolism and cellular signaling. LASS1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LASS1, or Longevity Assurance Gene 1, plays a crucial role in the synthesis of sphingolipids, which are essential for cell membrane integrity and signaling pathways. LASS1 is involved in various biological processes, including cell growth, differentiation, and apoptosis, making it a significant target for understanding diseases such as cancer and neurodegeneration. The study of LASS1 continues to reveal new insights into lipid-related disorders and potential therapeutic strategies. Researchers worldwide rely on LASS1 monoclonal antibodies to advance their understanding of cellular functions and disease mechanisms. LASS1 monoclonal antibodies from Santa Cruz Biotechnology enable precise detection and characterization of LASS1, supporting breakthrough discoveries in biomedical research. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific knowledge and accelerating therapeutic developments across the research community.